Ms Susan Lesli Hall, MA, LPC | |
4670 Fulton St E Ste 101, Ada, MI 49301-8409 | |
(616) 634-1262 | |
(616) 975-3163 |
Full Name | Ms Susan Lesli Hall |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 4670 Fulton St E Ste 101, Ada, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669613097 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 6401009884 (Michigan) | Primary |
Entity Name | Burke Group Counseling & Consulting Professionals Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639593627 PECOS PAC ID: 6103190335 Enrollment ID: O20170926003925 |
News Archive
ACR Image Metrix, a global imaging contract research organization (CRO) with expertise in imaging trial design, techniques and data extraction, hosted the Novel Medical Imaging Approaches for Early Drug Development Methods, Technical Issues and Case Studies event, which took place at the Boston Marriott Cambridge, in Cambridge Massachusetts, on September 16, 2010.
Evidence overwhelmingly supports a link between cognitive decline and cerebrovascular diseases such as atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Not only do individuals with cerebrovascular diseases have a much higher incidence of cortical microinfarcts (mini-strokes), but post-mortem histological and in vivo radiological studies also find that the burden of microinfarcts is significantly greater among people with vascular cognitive impairment and dementia (VCID) than in age-matched, non-demented individuals.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
Omeros Corporation today, in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, LLC in response to the Abbreviated New Drug Application (ANDA) filed by Par seeking FDA approval to market a generic version of Omeros' commercial drug Omidria (phenylephrine and ketorolac injection) 1%/0.3%.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Susan Lesli Hall, MA, LPC 611 Gladstone Dr Se, Grand Rapids, MI 49506-2818 Ph: (616) 634-1262 | Ms Susan Lesli Hall, MA, LPC 4670 Fulton St E Ste 101, Ada, MI 49301-8409 Ph: (616) 634-1262 |
News Archive
ACR Image Metrix, a global imaging contract research organization (CRO) with expertise in imaging trial design, techniques and data extraction, hosted the Novel Medical Imaging Approaches for Early Drug Development Methods, Technical Issues and Case Studies event, which took place at the Boston Marriott Cambridge, in Cambridge Massachusetts, on September 16, 2010.
Evidence overwhelmingly supports a link between cognitive decline and cerebrovascular diseases such as atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Not only do individuals with cerebrovascular diseases have a much higher incidence of cortical microinfarcts (mini-strokes), but post-mortem histological and in vivo radiological studies also find that the burden of microinfarcts is significantly greater among people with vascular cognitive impairment and dementia (VCID) than in age-matched, non-demented individuals.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
Omeros Corporation today, in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, LLC in response to the Abbreviated New Drug Application (ANDA) filed by Par seeking FDA approval to market a generic version of Omeros' commercial drug Omidria (phenylephrine and ketorolac injection) 1%/0.3%.
› Verified 6 days ago
Mr. John Ostrowski Jr., MA, LPC/S, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7955 Thornapple Club Dr Se, Ada, MI 49301 Phone: 616-881-6262 | |
Ms. Karolina Jevaltaite-harmon, LPC, LLMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 7195 Thornapple River Dr Se, Ada, MI 49301 Phone: 616-929-0248 | |
Shelby Negro, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7195 Thornapple River Dr Se Ste C, Ada, MI 49301 Phone: 586-854-6737 | |
Karen Feaster, Counselor Medicare: Not Enrolled in Medicare Practice Location: 455 Greentree Ln Ne, Ada, MI 49301 Phone: 616-340-2158 Fax: 269-686-5201 | |
Mrs. Maryam Jearbell Yahya, LLPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4764 Fulton St E Ste 204, Ada, MI 49301 Phone: 616-439-0007 | |
Robert B. Thompson, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8945 Vergennes St Se, Ada, MI 49301 Phone: 616-643-0869 | |
Molly Rose Wilson, PH.D., LLPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7195 Thornapple River Dr Se, Ada, MI 49301 Phone: 616-929-0248 |